DavidJFitzgeraldDOFACP, FCCP
Pulmonology • Albuquerque, NMCritical Care Medicine, Pleural Disease
Board Certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine
Dr. Fitzgerald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8300 Constitution Avenue NE
Albuquerque, NM 87110Phone+1 505-291-2100Fax+1 505-291-2102
Education & Training
Medical College of GeorgiaFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
University of Kansas (Wichita)Residency, Internal Medicine, 1989 - 1993
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1989
Certifications & Licensure
NM State License 2016 - 2027
CO State License 2007 - 2025
WY State License 2017 - 2025
DE State License 2017 - 2023
KS State License 1990 - 2022
ND State License 2015 - 2021
OK State License 2003 - 2008- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Publications & Presentations
PubMed
- 43 citationsImmunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent CancersNathan Simon, David J. FitzGerald
Toxins. 2016-05-04 - 22 citationsWhole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicityMatteo Pasetto, Antonella Antignani, Pinar Ormanoglu, Eugen Buehler, Rajarshi Guha
Proceedings of the National Academy of Sciences of the United States of America. 2015-03-10 - 14 citationsABT-737 promotes the dislocation of ER luminal proteins to the cytosol, including Pseudomonas exotoxin.Antonella Antignani, Robert Sarnovsky, David J. FitzGerald
Molecular Cancer Therapeutics. 2014-04-16
Grant Support
- Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseNational Cancer Institute2010–2011
- Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseDivision Of Basic Sciences - Nci2009
- Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseNational Cancer Institute2007–2008
- Bio-Therapies For The Treatment Of Cancer And InfectiousDivision Of Basic Sciences - Nci2002–2006
- Bio-Therapies For The Treatment Of Cancer And InfectionsDivision Of Basic Sciences - Nci2004
- Bio-Therapies For Cancer And Infectious DiseaseDivision Of Basic Sciences - Nci2001
- Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseDivision Of Basic Sciences - Nci2000
- Bio-Therapies For The Treatment Of Cancer And AIDSDivision Of Basic Sciences - Nci1999
- Targeted Therapies For Treatment Of Cancer And AIDSDivision Of Basic Sciences - Nci1997–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
